Literature DB >> 14642564

Bufalin influences the repair of X-ray-induced DNA breaks in Chinese hamster cells.

Nuria Pastor1, Felipe Cortés.   

Abstract

The bufadienolide bufalin, a component of the Chinese medicine chan'su, has been reported to selectively inhibit the growth of various lines of human cancer cells, due at least in part to its specific effect on topoisomerase (topo) II. We have treated Chinese hamster ovary (CHO) cells with doses of bufalin that result in a dramatic reduction in both the level and catalytic activity of topo II without any concomitant induction of DNA damage, as assessed by the comet assay. When cells were pre-treated with bufalin and then irradiated with X-rays, a follow-up study revealed that the kinetics of DNA repair was clearly affected, with a general delay in the restoration of DNA to the situation observed in non-irradiated controls. The possible involvement of topo II in radiation damage repair is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14642564     DOI: 10.1016/j.dnarep.2003.08.001

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  7 in total

1.  Bufalin inhibits glycolysis-induced cell growth and proliferation through the suppression of Integrin β2/FAK signaling pathway in ovarian cancer.

Authors:  Haoran Li; Shuang Hu; Yangyang Pang; Mengjiao Li; Lihua Chen; Fei Liu; Mingming Liu; Ziliang Wang; Xi Cheng
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

2.  Inhibition of topoisomerase IIα sensitizes FaDu cells to ionizing radiation by diminishing DNA repair.

Authors:  Ekram M Saleh
Journal:  Tumour Biol       Date:  2015-06-17

3.  Inhibitors of the sodium potassium ATPase that impair herpes simplex virus replication identified via a chemical screening approach.

Authors:  Allen W Dodson; Travis J Taylor; David M Knipe; Donald M Coen
Journal:  Virology       Date:  2007-06-01       Impact factor: 3.616

4.  Lanatoside C suppressed colorectal cancer cell growth by inducing mitochondrial dysfunction and increased radiation sensitivity by impairing DNA damage repair.

Authors:  Mi Ae Kang; Mi-Sook Kim; Wonwoo Kim; Jee-Hyun Um; Young-Joo Shin; Jie-Young Song; Jae-Hoon Jeong
Journal:  Oncotarget       Date:  2016-02-02

5.  Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221.

Authors:  Jianjun Zhang; Jingjing Sha; Yan Zhou; Kun Han; Yaling Wang; Yang Su; Xiuyi Yin; Haiyan Hu; Yang Yao
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-15       Impact factor: 2.629

6.  Targeting poly (ADP-ribose) polymerase partially contributes to bufalin-induced cell death in multiple myeloma cells.

Authors:  He Huang; Yang Cao; Wei Wei; Wei Liu; Shao-Yong Lu; Yu-Bao Chen; Yan Wang; Hua Yan; Ying-Li Wu
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

7.  Bufalin induces DNA damage response under hypoxic condition in myeloma cells.

Authors:  Eri Fujii; Yuki Inada; Misaki Kakoki; Nao Nishimura; Shinya Endo; Shiho Fujiwara; Naoko Wada; Yawara Kawano; Yutaka Okuno; Toshiya Sugimoto; Hiroyuki Hata
Journal:  Oncol Lett       Date:  2018-02-21       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.